APA (7th ed.) Citation

LF, G., E, C., S, H., M, A., D, C., M, D., . . . J, d. C. (2026). PD-L1 expression scoring using artificial intelligence algorithms in non-small cell lung cancer harbouring ROS1 fusions: Potential clinical-biological significance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 28(2), 484. https://doi.org/10.1007/s12094-025-04013-w

Chicago Style (17th ed.) Citation

LF, García, et al. "PD-L1 Expression Scoring Using Artificial Intelligence Algorithms in Non-small Cell Lung Cancer Harbouring ROS1 Fusions: Potential Clinical-biological Significance." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 28, no. 2 (2026): 484. https://doi.org/10.1007/s12094-025-04013-w.

MLA (9th ed.) Citation

LF, García, et al. "PD-L1 Expression Scoring Using Artificial Intelligence Algorithms in Non-small Cell Lung Cancer Harbouring ROS1 Fusions: Potential Clinical-biological Significance." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 28, no. 2, 2026, p. 484, https://doi.org/10.1007/s12094-025-04013-w.